Changzhou Qianhong Biopharma CO.,LTD

SZSE:002550 Stock Report

Market Cap: CN¥7.6b

Changzhou Qianhong BiopharmaLTD Management

Management criteria checks 3/4

Changzhou Qianhong BiopharmaLTD's CEO is Ke Wang, appointed in Sep 2014, has a tenure of 10.17 years. directly owns 5.07% of the company’s shares, worth CN¥386.16M. The average tenure of the management team and the board of directors is 3.8 years and 3.8 years respectively.

Key information

Ke Wang

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentagen/a
CEO tenure10.2yrs
CEO ownership5.1%
Management average tenure3.8yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Do Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Warrant Your Attention?

Nov 18
Do Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Warrant Your Attention?

Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Held Back By Insufficient Growth Even After Shares Climb 37%

Oct 21
Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Held Back By Insufficient Growth Even After Shares Climb 37%

Here's Why Changzhou Qianhong BiopharmaLTD (SZSE:002550) Can Manage Its Debt Responsibly

Aug 21
Here's Why Changzhou Qianhong BiopharmaLTD (SZSE:002550) Can Manage Its Debt Responsibly

Changzhou Qianhong BiopharmaLTD (SZSE:002550) Has Affirmed Its Dividend Of CN¥0.12

May 26
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Has Affirmed Its Dividend Of CN¥0.12

Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Looks Just Right With A 26% Price Jump

May 21
Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Looks Just Right With A 26% Price Jump

Investors Can Find Comfort In Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Quality

May 02
Investors Can Find Comfort In Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Quality

Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?

Mar 24
Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?

CEO

Ke Wang (41 yo)

10.2yrs

Tenure

CN¥1,297,000

Compensation

Mr. Ke Wang serves as Non-Independent Director at Changzhou Qianhong Biopharma Co.,Ltd. since September 10, 2014 and serves as its General Manager since September 10, 2014.


Leadership Team

NamePositionTenureCompensationOwnership
Ke Wang
GM & Non-Independent Director10.2yrsCN¥1.30m5.07%
CN¥ 386.2m
Yi Yao
CFO & Board Secretaryno dataCN¥465.40k0.012%
CN¥ 913.4k
Xiang Zhou
Deputy GM & Non-Independent Director7.3yrsCN¥776.10k0.018%
CN¥ 1.4m
Lijun Wei
Chief Engineer & Director3.8yrsCN¥556.00k0.015%
CN¥ 1.1m
Chizhou Jiang
Non-Independent Director & Deputy GMno dataCN¥785.80kno data
Aiqun Xiao
Audit Directorless than a yearCN¥517.10k0.016%
CN¥ 1.2m
Juanwei Hua
Deputy Director of Project Implementation Office & Non-Employee Supervisor3.8yrsno data0.010%
CN¥ 767.2k

3.8yrs

Average Tenure

42yo

Average Age

Experienced Management: 002550's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ke Wang
GM & Non-Independent Director10.2yrsCN¥1.30m5.07%
CN¥ 386.2m
Xiang Zhou
Deputy GM & Non-Independent Director7.3yrsCN¥776.10k0.018%
CN¥ 1.4m
Lijun Wei
Chief Engineer & Directorno dataCN¥556.00k0.015%
CN¥ 1.1m
Chizhou Jiang
Non-Independent Director & Deputy GM3.8yrsCN¥785.80kno data
Juanwei Hua
Deputy Director of Project Implementation Office & Non-Employee Supervisor3.8yrsno data0.010%
CN¥ 767.2k
Jun Liu
Chairman of the Supervisory Boardless than a yearCN¥901.00k1.93%
CN¥ 146.5m
Yaofang Wang
Chairman16.8yrsCN¥369.50k20.44%
CN¥ 1.6b
Gang Zhao
Vice Chairman16.8yrsCN¥526.60k7.87%
CN¥ 598.7m
Tao Hai
Non-Independent Director & Deputy GMless than a yearCN¥888.00kno data
Shengxiang Ren
Independent Director3.8yrsCN¥100.00kno data
Ao Ning
Independent Director3.8yrsCN¥100.00kno data
Yuyu Gao
Independent Directorless than a yearno datano data

3.8yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 002550's board of directors are considered experienced (3.8 years average tenure).